Want to see HNGE full AI Analyst Report?

Hinge Health, Inc. Class A (HNGE) Stock Forecast & Price Target

253 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HNGE Analyst Ratings

Strong Buy

13 Buy

1 Hold

0 Sell

Based on 14 analysts giving stock ratings to

Hinge

Health, Inc. Class A

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HNGE Stock 12 Month Forecast

Average Price Target

$110.75

▲(26.79% Upside)

Based on 14 Wall Street analysts offering 12 month price targets for Hinge Health, Inc. Class A in the last 3 months. The average price target is $110.75 with a high forecast of $140.00 and a low forecast of $90.00. The average price target represents a 26.79% change from the last price of $87.35.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"34":"$34","141":"$141","60.75":"$60.8","87.5":"$87.5","114.25":"$114.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":140,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$140.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":110.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$110.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$90.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[34,60.75,87.5,114.25,141],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,97.94,101.17538461538462,104.41076923076923,107.64615384615385,110.88153846153845,114.11692307692307,117.35230769230769,120.58769230769231,123.82307692307693,127.05846153846153,130.29384615384615,133.52923076923076,136.76461538461538,{"y":140,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,97.94,98.92538461538462,99.91076923076923,100.89615384615385,101.88153846153845,102.86692307692307,103.85230769230769,104.83769230769231,105.82307692307693,106.80846153846154,107.79384615384615,108.77923076923076,109.76461538461538,{"y":110.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,97.94,97.32923076923076,96.71846153846154,96.1076923076923,95.49692307692308,94.88615384615385,94.27538461538461,93.66461538461539,93.05384615384615,92.44307692307692,91.8323076923077,91.22153846153846,90.61076923076924,{"y":90,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":48.75,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":49.76,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.96,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.45,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.23,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.86,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.49,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.43,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.92,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.07,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.71,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.02,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.94,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$140.00

Average Price Target$110.75

Lowest Price Target$90.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Tomer Zilberman

Bank of America Securities

$110→$130

Buy

48.83%

Upside

Reiterated

10/23/26

Hinge Health price target raised to $130 from $110 at BofAHinge Health price target raised to $130 from $110 at BofA

Scott Schoenhaus

KeyBanc

$125→$140

Buy

60.27%

Upside

Reiterated

10/16/26

Rishi Jaluria

RBC Capital

$110

Buy

25.93%

Upside

Reiterated

10/15/26

Hinge Health, Inc. Class A (HNGE) Receives a Buy from RBC Capital

Saket Kalia

Barclays

$100→$110

Buy

25.93%

Upside

Assigned

10/12/26

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (NASDAQ: ASND), Argenx Se (NASDAQ: ARGX) and Hinge Health, Inc. Class A (NYSE: HNGE)

Craig Hettenbach

Morgan Stanley

$117

Buy

33.94%

Upside

Reiterated

10/12/26

Analysts Offer Insights on Healthcare Companies: Tilray (NASDAQ: TLRY) and Hinge Health, Inc. Class A (NYSE: HNGE)

Terry Tillman

Truist Financial

―

Buy

―

Reiterated

09/28/26

Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (NYSE: HNGE) and Agilon Health (NYSE: AGL)

Vikram Kesavabhotla

Robert W. Baird

$85→$90

Hold

3.03%

Upside

Reiterated

09/22/26

Hinge Health price target raised to $90 from $85 at BairdHinge Health price target raised to $90 from $85 at Baird

David Grossman

Stifel Nicolaus

$96→$115

Buy

31.65%

Upside

Reiterated

09/08/26

Hinge Health price target raised to $115 from $96 at StifelHinge Health price target raised to $115 from $96 at Stifel

Eugene Mannheimer

Freedom Capital Markets

$78→$103

Buy

17.92%

Upside

Reiterated

08/10/26

Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (NYSE: HNGE) and Precision BioSciences (NASDAQ: DTIL)

Richard Close

Canaccord Genuity

$100→$105

Buy

20.21%

Upside

Reiterated

08/05/26

Hinge Health price target raised to $105 from $100 at CanaccordHinge Health price target raised to $105 from $100 at Canaccord

Aaron Kimson

Citizens JMP

$96→$107

Buy

22.50%

Upside

Reiterated

08/05/26

Hinge Health price target raised to $107 from $96 at CitizensHinge Health price target raised to $107 from $96 at Citizens

Ryan MacDonald

Needham

$76→$97

Buy

11.05%

Upside

Reiterated

08/05/26

Hinge Health Buy Rating Reaffirmed as Growth Accelerates and Price Target Raised from $76 to $97

Ryan Daniels

William Blair

―

Buy

―

Reiterated

08/04/26

Hinge Health Earns Buy Rating on Robust Double-Digit Growth and Expanding Commercial Footprint

Elizabeth Anderson CFA

Evercore ISI

$105

Buy

20.21%

Upside

Reiterated

08/04/26

Evercore ISI Reaffirms Their Buy Rating on Hinge Health, Inc. Class A (HNGE)

Stan Berenshteyn

Wells Fargo

$80→$90

Buy

3.03%

Upside

Assigned

06/24/26

Analysts Are Bullish on These Healthcare Stocks: Hinge Health, Inc. Class A (HNGE), Natera (NTRA)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Tomer Zilberman

Bank of America Securities

$110→$130

Buy

48.83%

Upside

Reiterated

10/23/26

Hinge Health price target raised to $130 from $110 at BofAHinge Health price target raised to $130 from $110 at BofA

Scott Schoenhaus

KeyBanc

$125→$140

Buy

60.27%

Upside

Reiterated

10/16/26

Rishi Jaluria

RBC Capital

$110

Buy

25.93%

Upside

Reiterated

10/15/26

Hinge Health, Inc. Class A (HNGE) Receives a Buy from RBC Capital

Saket Kalia

Barclays

$100→$110

Buy

25.93%

Upside

Assigned

10/12/26

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (NASDAQ: ASND), Argenx Se (NASDAQ: ARGX) and Hinge Health, Inc. Class A (NYSE: HNGE)

Craig Hettenbach

Morgan Stanley

$117

Buy

33.94%

Upside

Reiterated

10/12/26

Analysts Offer Insights on Healthcare Companies: Tilray (NASDAQ: TLRY) and Hinge Health, Inc. Class A (NYSE: HNGE)

Terry Tillman

Truist Financial

―

Buy

―

Reiterated

09/28/26

Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (NYSE: HNGE) and Agilon Health (NYSE: AGL)

Vikram Kesavabhotla

Robert W. Baird

$85→$90

Hold

3.03%

Upside

Reiterated

09/22/26

Hinge Health price target raised to $90 from $85 at BairdHinge Health price target raised to $90 from $85 at Baird

David Grossman

Stifel Nicolaus

$96→$115

Buy

31.65%

Upside

Reiterated

09/08/26

Hinge Health price target raised to $115 from $96 at StifelHinge Health price target raised to $115 from $96 at Stifel

Eugene Mannheimer

Freedom Capital Markets

$78→$103

Buy

17.92%

Upside

Reiterated

08/10/26

Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (NYSE: HNGE) and Precision BioSciences (NASDAQ: DTIL)

Richard Close

Canaccord Genuity

$100→$105

Buy

20.21%

Upside

Reiterated

08/05/26

Hinge Health price target raised to $105 from $100 at CanaccordHinge Health price target raised to $105 from $100 at Canaccord

Aaron Kimson

Citizens JMP

$96→$107

Buy

22.50%

Upside

Reiterated

08/05/26

Hinge Health price target raised to $107 from $96 at CitizensHinge Health price target raised to $107 from $96 at Citizens

Ryan MacDonald

Needham

$76→$97

Buy

11.05%

Upside

Reiterated

08/05/26

Hinge Health Buy Rating Reaffirmed as Growth Accelerates and Price Target Raised from $76 to $97

Ryan Daniels

William Blair

―

Buy

―

Reiterated

08/04/26

Hinge Health Earns Buy Rating on Robust Double-Digit Growth and Expanding Commercial Footprint

Elizabeth Anderson CFA

Evercore ISI

$105

Buy

20.21%

Upside

Reiterated

08/04/26

Evercore ISI Reaffirms Their Buy Rating on Hinge Health, Inc. Class A (HNGE)

Stan Berenshteyn

Wells Fargo

$80→$90

Buy

3.03%

Upside

Assigned

06/24/26

Analysts Are Bullish on These Healthcare Stocks: Hinge Health, Inc. Class A (HNGE), Natera (NTRA)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

PTGXProtagonist Therapeutics

SIBNSI-Bone

IMUXImmunic

MDWDMediwound

HROWHarrow Health

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Hinge Health, Inc. Class A

3 Months

Saket KaliaBarclays

Success Rate

10/12 ratings generated profit

Average Return

+27.86%

Copying Saket Kalia's trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +27.86% per trade.

1 Year

Elizabeth Anderson CFAEvercore ISI

Success Rate

8/8 ratings generated profit

Average Return

+118.06%

Copying Elizabeth Anderson CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +118.06% per trade.

2 Years

Elizabeth Anderson CFAEvercore ISI

Success Rate

8/8 ratings generated profit

Average Return

+141.52%

Copying Elizabeth Anderson CFA's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +141.52% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HNGE Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HNGE has received 21 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. HNGE average Analyst price target in the past 3 months is 110.75.

Each month's total comprises the sum of three months' worth of ratings.

HNGE Financial Forecast

HNGE Earnings Forecast

Next quarter’s earnings estimate for HNGE is $0.57 with a range of $0.42 to $0.65. The previous quarter’s EPS was $0.59. HNGE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year HNGE has Performed in-line its overall industry.

HNGE Sales Forecast

Next quarter’s sales forecast for HNGE is $224.78M with a range of $223.20M to $229.80M. The previous quarter’s sales results were $212.82M. HNGE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year HNGE has Performed in-line its overall industry.

HNGE Stock Forecast FAQ

What is HNGE’s average 12-month price target, according to analysts?

Based on analyst ratings, Hinge Health, Inc. Class A’s 12-month average price target is 110.75.

What is HNGE’s upside potential, based on the analysts’ average price target?

Hinge Health, Inc. Class A has 26.79% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HNGE a Buy, Sell or Hold?

Hinge Health, Inc. Class A has a consensus rating of Strong Buy which is based on 13 buy ratings, 1 hold ratings and 0 sell ratings.

What is Hinge Health, Inc. Class A’s price target?

The average price target for Hinge Health, Inc. Class A is 110.75. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $140.00 ,the lowest forecast is $90.00. The average price target represents 26.79% Increase from the current price of $87.35.

What do analysts say about Hinge Health, Inc. Class A?

Hinge Health, Inc. Class A’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.

How can I buy shares of HNGE?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Hinge Health, Inc. Class A (HNGE) Stock Forecast & Price Target

HNGE Analyst Ratings

HNGE Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Hinge Health, Inc. Class A

HNGE Analyst Recommendation Trends

HNGE Financial Forecast

HNGE Earnings Forecast

HNGE Sales Forecast

HNGE Stock Forecast FAQ

Detailed List of Analyst Forecasts